Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 21905977)

1.

IFN beta 1b induced celiac disease.

Fernández-Salazar L, Álvarez-Quiñones M, González Hernández JM, Fraile A, Mayor E, Arranz E, Garrote JA.

Scand J Gastroenterol. 2011 Dec;46(12):1525-6. doi: 10.3109/00365521.2011.613950. Epub 2011 Sep 12. No abstract available.

PMID:
21905977
2.

Arthritis during interferon beta-1b treatment in multiple sclerosis.

Altintas A, Alici Y, Melikoğlu M, Siva A.

Mult Scler. 2002 Dec;8(6):534-6.

PMID:
12474998
3.

Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis.

Szilasiová J, Gdovinová Z, Jautová J, Baloghová J, Ficová M, Bohus P.

Clin Neuropharmacol. 2009 Sep-Oct;32(5):301-3. doi: 10.1097/WNF.0b013e3181a2b5fd.

PMID:
19820436
4.

A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.

Albani C, Albani G.

J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):418. No abstract available.

5.

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.

Ferrarini AM, Sivieri S, Buttarello M, Facchinetti A, Perini P, Gallo P.

Mult Scler. 1998 Jun;4(3):174-7.

PMID:
9762669
6.

Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.

Kumasaka R, Nakamura N, Shirato K, Fujita T, Murakami R, Shimada M, Nakamura M, Osawa H, Yamabe H, Okumura K.

Clin Exp Nephrol. 2006 Sep;10(3):222-5.

PMID:
17009081
7.

Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.

Zwibel HL; Copolymer-1 Treatment Study Principal Investigators.

Acta Neurol Scand. 2006 Jun;113(6):378-86.

PMID:
16674604
8.

[Skin reactions to interferon alpha in a series of 92 patients with multiple sclerosis].

Fortuño Y, Marcoval J, Gallego I, Moreno A, Arbizu T, Peyrí J.

Med Clin (Barc). 1999 Oct 16;113(12):447-8. Spanish.

PMID:
10570511
10.
11.

HLA-DQ associations with autoimmune disease.

Altmann DM.

Autoimmunity. 1992;14(1):79-83. Review. No abstract available.

PMID:
1299350
12.
13.

[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b].

Río J, Marzo ME, Tintoré M, Borrás C, Montalbán X.

Neurologia. 1998 Nov;13(9):422-6. Spanish.

PMID:
9883016
14.

Molecular basis and functional importance of some disease-associated HLA polymorphisms.

Thorsby E, Lundin KE, Rønningen KS, Sollid LM, Vartdal F.

Tissue Antigens. 1989 Jul;34(1):39-49. Review. No abstract available.

PMID:
2683208
15.

[Interferon beta-1b retinopathy during a treatment for multiple sclerosis].

Sommer S, Sablon JC, Zaoui M, Rozot P, Hosni A.

J Fr Ophtalmol. 2001 May;24(5):509-12. French.

16.

Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.

Gono T, Matsuda M, Shimojima Y, Kaneko K, Murata H, Ikeda S.

J Clin Neurosci. 2007 Oct;14(10):997-1000. Epub 2007 Jul 31.

PMID:
17669654
17.

Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?

Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L; Betaferon Safety Trial (BEST) Study Group.

J Interferon Cytokine Res. 2002 Feb;22(2):245-55. Erratum in: J Interferon Cytokine Res 2002 Apr;22(4):504.

PMID:
11911808
18.

Autoimmune hypothyroidism associated with interferon beta-1b treatment in two patients with multiple sclerosis.

McDonald ND, Pender MP.

Aust N Z J Med. 2000 Apr;30(2):278-9. No abstract available.

PMID:
10833126
19.

Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.

Rotondi M, Mazziotti G, Biondi B, Manganella G, Del Buono AD, Montella P, di Cristofaro M, Di Iorio G, Amato G, Carella C.

J Endocrinol Invest. 2000 May;23(5):321-4.

PMID:
10882151
20.

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.

Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E.

J Exp Med. 1989 Jan 1;169(1):345-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk